Search Results - Dirk Jan A.R. Moes

Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology by Etienne Chatelut, Jeroen J. M. A. Hendrikx, Jennifer Martin, Joseph Ciccolini, Dirk Jan A. R. Moes

Connect to this object online.

A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors by Anyue Yin, Dirk Jan A.R. Moes, Johan G.C. vanHasselt, Jesse J. Swen, Henk‐Jan Guchelaar

Connect to this object online.

The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients by Teun van Gelder, Soufian Meziyerh, Soufian Meziyerh, Jesse J. Swen, Aiko P. J. de Vries, Aiko P. J. de Vries, Dirk Jan A. R. Moes

Connect to this object online.

Therapeutic Drug Monitoring of Conditioning Agents in Pediatric Allogeneic Stem Cell Transplantation; Where do We Stand? by M. Y. Eileen C. van der Stoep, Lisa V. E. Oostenbrink, Robbert G. M. Bredius, Dirk Jan A. R. Moes, Henk-Jan Guchelaar, Juliette Zwaveling, Arjan C. Lankester

Connect to this object online.

Meltdose Tacrolimus Population Pharmacokinetics and Limited Sampling Strategy Evaluation in Elderly Kidney Transplant Recipients by Jasper Kamp, Tom C. Zwart, Soufian Meziyerh, Paul J. M. van der Boog, Esther E. Nijgh, Koen van Duin, Aiko P. J. de Vries, Dirk Jan A. R. Moes

Connect to this object online.

Monitoring of Ex Vivo Cyclosporin a Activity in Healthy Volunteers Using T Cell Function Assays in Relation to Whole Blood and Cellular Pharmacokinetics by Aliede E. in 't Veld, Manon A. A. Jansen, Bertine W. Huisman, Mascha Schoonakker, Marieke L. de Kam, Dirk Jan A. R. Moes, Mariëtte I. E. van Poelgeest, Jacobus Burggraaf, Matthijs Moerland

Connect to this object online.

Physiologically based pharmacokinetic modeling of tacrolimus for food-drug and CYP3A drug-drug-gene interaction predictions by Helena Leonie Hanae Loer, Denise Feick, Simeon Rüdesheim, Dominik Selzer, Matthias Schwab, Donato Teutonico, Sebastian Frechen, Maaike van derLee, Dirk Jan A. R. Moes, Jesse J. Swen, Thorsten Lehr

Connect to this object online.

The effect of genetic variants in the transcription factor TSPYL family on the CYP3A4 mediated cyclosporine metabolism in kidney transplant patients by Qinglian Zhai, Dirk Jan A. R. Moes, Teun vanGelder, Maaike van derLee, Jan‐Stephan Sanders, Frederike J. Bemelman, Johan W. deFijter, Kathrin Klein, Matthias Schwab, Jesse J. Swen

Connect to this object online.

Immune Monitoring of Mycophenolate Mofetil Activity in Healthy Volunteers Using <i>Ex Vivo</i> T Cell Function Assays by Aliede E. in 't Veld, Manon A. A. Jansen, Marieke L. de Kam, Yalҫin Yavuz, Dirk Jan A. R. Moes, Kathalijne A. Oudhoff, Mariette I. E. van Poelgeest, Jacobus Burggraaf, Matthijs Moerland

Connect to this object online.

Physiologically‐based pharmacokinetic modeling of quinidine to establish a CYP3A4, P‐gp, and CYP2D6 drug-drug-gene interaction network by Denise Feick, Simeon Rüdesheim, Fatima Zahra Marok, Dominik Selzer, Helena Leonie Hanae Loer, Donato Teutonico, Sebastian Frechen, Maaike van derLee, Dirk Jan A. R. Moes, Jesse J. Swen, Matthias Schwab, Thorsten Lehr

Connect to this object online.

Immune responsiveness in stable kidney transplantation patients: Complete inhibition of T‐cell proliferation but residual T‐cell activity during maintenance immunosuppressive treat... by Aliede E. in 't Veld, Boukje C. Eveleens Maarse, Maria J. Juachon, Soufian Meziyerh, Aiko P. J. deVries, Aline L. vanRijn, Mariet C. W. Feltkamp, Dirk Jan A. R. Moes, Jacobus Burggraaf, Matthijs Moerland

Connect to this object online.

Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib by Anyue Yin, G. D. Marijn Veerman, Johan G. C. vanHasselt, Christi M. J. Steendam, Hendrikus Jan Dubbink, Henk‐Jan Guchelaar, Lena E. Friberg, Anne‐Marie C. Dingemans, Ron H. J. Mathijssen, Dirk Jan A. R. Moes

Connect to this object online.